NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds V.F. Corporation (“VFC” or the “Company”) (NYSE:VFC) investors of the November 12, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired V.F. Corporation securities, have information, or would like to learn more, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or i ...

Core Viewpoint - A securities class action lawsuit has been filed against Fluor Corporation for failing to disclose material information during the class period from February 18, 2025, to July 31, 2025, which is in violation of federal securities laws [3]. Group 1: Lawsuit Details - Investors have until November 14, 2025, to file lead plaintiff applications in the lawsuit against Fluor Corporation [1]. - The lawsuit is pending in the United States District Court for the Northern District of Texas [1]. - The case is titled Maglione v. Fluor Corporation, et al., No. 25-cv-02496 [5]. Group 2: Financial Performance - On August 1, 2025, Fluor announced its Q2 2025 financial results, reporting a non-GAAP EPS of $0.43, which missed consensus estimates by $0.13 [4]. - The company's revenue for Q2 2025 was $3.98 billion, reflecting a 5.9% year-over-year decline and missing consensus estimates by $570 million [4]. - The financial outlook for FY 2025 was negatively revised, with adjusted EBITDA guidance lowered to $475 million to $525 million from a prior range of $575 million to $675 million [4]. - Adjusted EPS guidance was also reduced to $1.95 to $2.15 per share, down from a previous range of $2.25 to $2.75 per share [4]. Group 3: Market Reaction - Following the announcement of the financial results, Fluor's share price fell by $15.35, or 27.04%, closing at $41.42 per share on August 1, 2025 [5].

, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fluor Corporation (NYSE: FLR). Shareholders who purchased shares of FLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who h ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the October 28, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Dow securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 28, 2025 [2] - The lawsuit alleges that Dow made false and misleading statements regarding its ability to manage macroeconomic and tariff-related challenges, overstating its financial flexibility and downplaying the negative impacts on its business [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3]

Core Viewpoint - ClaimsFiler informs investors about the deadline of November 14, 2025, to file lead plaintiff applications in a securities class action lawsuit against Fluor Corporation for failing to disclose material information during the Class Period from February 18, 2025, to July 31, 2025 [1][3]. Financial Performance - On August 1, 2025, Fluor announced its Q2 2025 financial results, reporting a non-GAAP EPS of $0.43, which missed consensus estimates by $0.13, and revenue of $3.98 billion, reflecting a 5.9% year-over-year decline and missing estimates by $570 million due to increased costs from subcontractor design errors, price hikes, scheduling delays, and reduced capital spending by customers [4]. - The company revised its FY 2025 financial outlook, guiding adjusted EBITDA to $475 million to $525 million, down from prior guidance of $575 million to $675 million, and adjusted EPS to $1.95 to $2.15 per share, down from previous guidance of $2.25 to $2.75 per share [4]. Market Reaction - Following the financial announcement, Fluor's share price dropped by $15.35, or 27.04%, closing at $41.42 per share on August 1, 2025 [5].

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you suffered losses in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may a ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options If you suffered losses in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983- 9330Â (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 2, 2025 /PR ...

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating it ...

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for alleged misleading statements and failure to disclose significant issues regarding its operations during the Class Period from December 12, 2024, to September 5, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Quanex's tooling and equipment maintenance procedures in its Tyman Mexico facility were significantly underinvested, leading to degraded conditions [5]. - It is alleged that these conditions were near catastrophic levels, which would likely incur significant costs and delay expected benefits from the Tyman integration [5]. - The lawsuit asserts that Quanex had previously identified these issues, and the positive statements made by the defendants regarding the company's business and prospects were materially misleading [5]. Group 2: Investor Information - Investors who purchased Quanex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased securities of Jasper Therapeutics, Inc. during the specified Class Period, alleging misleading statements and failures in compliance with manufacturing regulations [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of Jasper Therapeutics securities between November 30, 2023, and July 3, 2025 [1]. - The lawsuit claims that Jasper lacked necessary controls to ensure third-party manufacturers complied with cGMP regulations, which could negatively impact clinical trial results and the commercial prospects of its products [5]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent the class in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4].